Icon (ICLR) Income from Non-Controlling Interests (2019 - 2020)
Icon (ICLR) posted quarterly Income from Non-Controlling Interests of $1.3 million for Q4 2020, up 248.24% year-over-year from $363538.7 in Q1 2020, and up 300.0% quarter-over-quarter from -$633000.0 in Q1 2020.
Icon (ICLR) Income from Non-Controlling Interests (2019 - 2020) Analysis & Trends
Icon (ICLR) has reported Income from Non-Controlling Interests for 2 consecutive years, with $1.3 million the latest figure, recorded in Q4 2020.
- In Q4 2020, Income from Non-Controlling Interests rose 248.24% year-over-year to $1.3 million; the TTM figure through Sep 2021 stood at $1.3 million (up 185.14% YoY), while the FY2020 annual figure was $633000.0, down 66.15% from the prior year.
- Income from Non-Controlling Interests grew to $1.3 million in Q4 2020 per ICLR's latest filing, from -$633000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $1.3 million in Q4 2020 and bottomed at -$854000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 2.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 400,000.00 |
| 10 | Icon | 13.32 Bn | 13.32 Bn | 479.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -633,000.00 |
| Dec 31, 2019 | -854,000.00 |
| Sep 30, 2019 | -658,000.00 |
| Jun 30, 2019 | -358,000.00 |